Inogla-M 500 Tablet SR
By Inogla-M
Rx
10 Tablet SR in a Strip

Composition
Metformin(500mg) + Teneligliptin(20mg)

Manufacturer - Wockhardt Ltd
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after
June, 2026

liver
Inogla-M 500 Tablet SR is not recommended for use in patients with liver disease. It is deemed unsafe for individuals with liver issues, and it is advised to avoid using this medication if you have a liver condition. Kindly consult with your doctor regarding suitable alternatives or additional guidance for your specific situation.

kidney
Inogla-M 500 Tablet SR should be used carefully in patients with kidney issues. Adjusting the dosage may be necessary. Avoid using this medication in severe kidney disease cases. It's advised to monitor kidney function regularly during treatment.

alcohol
It is unsafe to drink alcohol while taking Inogla-M 500 Tablet SR.

driving
"Caution should be exercised while driving after taking Inogla-M 500 Tablet SR. Avoid driving if you have symptoms that may hinder focus and reaction time."

pregnancy
Inogla-M 500 Tablet SR is not recommended during pregnancy as animal studies suggest potential harm to the developing baby. Consult your doctor to discuss potential risks and benefits before using this medication.

breastfeeding
Inogla-M 500 Tablet SR is probably unsafe during breastfeeding as limited data suggests it may pass into breastmilk, potentially harming the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹178.5
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024